SMITH II, Leon M.,LADZIATA, Vladimir,DELUCCA, Indawati,PINTO, Donald,ORWAT, Michael J.,DILGER, Andrew K.,PABBISETTY, Kumar Balashanmuga,YANG, Wu,SHAW, Scott A.,GLUNZ, Peter W.,PANDA, Manoranjan
申请号:
SG11201805927Y
公开号:
SG11201805927YA
申请日:
2017.01.13
申请国别(地区):
SG
年份:
2018
代理人:
摘要:
or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.